Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fexofenadine in mild to moderate persistent asthma
NCT00044811Phase 3Completed
- Sponsor
- Sanofi
- Start
- Mar 2002
- Primary completion
- Oct 2003
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of fexofenadine in asthma, sponsored by Sanofi. Started Mar 2002; status: completed.
02
Drugs
fexofenadine
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00044811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00044811.